BRASILIA (Reuters) – Brazil’s health regulator Anvisa said on Thursday it has approved the use of Pfizer’s COVID-19 vaccine for children aged from 5 to 11 years old.
The regulator said the benefits of mass-immunization far outweigh the risks associated with the vaccine. It remains unclear, however, as to when Brazil might roll out doses to this age group.
(Reporting by Ricardo Brito; Writing by Peter Frontini; editing by Stephen Eisenhammer)
